← Evidence map

ArticleSignal transduction and targeted therapy2024

2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosus.

Huiqi Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39551768